English  |  正體中文  |  简体中文  |  總筆數 :2828323  
造訪人次 :  32250459    線上人數 :  1148
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"tsung hao liu"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 1-18 / 18 (共1頁)
1 
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2022-04-07T01:43:09Z Minimum cycle bases of weighted outerplanar graphs TSUNG-HAO LIU; Lu H.-I.
臺大學術典藏 2022-04-07T01:43:08Z Minimum cycle bases of weighted outerplanar graphs TSUNG-HAO LIU; Lu H.-I.
臺大學術典藏 2022-04-07T01:43:07Z Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy Shen Y.-C.; Yeh C.-P.; Jeng Y.-M.; Hsu C.; Hsu C.-H.; Lin Z.-Z.; Shao Y.-Y.; Lu L.-C.; TSUNG-HAO LIU; Chen C.-H.; Cheng A.-L.
臺大學術典藏 2022-04-07T01:43:07Z Revisiting hepatic artery infusion chemotherapy in the treatment of advanced hepatocellular carcinoma Chen C.-T.; TSUNG-HAO LIU; Shao Y.-Y.; Liu K.-L.; Liang P.-C.; Lin Z.-Z.
臺大學術典藏 2021-03-19T01:54:22Z Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation Chen K.-F.; Yu H.-C.; TSUNG-HAO LIU; Lee S.-S.; Chen P.-J.; Cheng A.-L.
臺大學術典藏 2021-03-19T01:54:21Z CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells Chen K.-F.; Liu C.-Y.; Lin Y.-C.; Yu H.-C.; TSUNG-HAO LIU; Hou D.-R.; Chen P.-J.; Cheng A.-L.
臺大學術典藏 2021-03-19T01:54:21Z Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3 Chen K.-F.; Tai W.-T.; TSUNG-HAO LIU; Huang H.-P.; Lin Y.-C.; Shiau C.-W.; Li P.-K.; Chen P.-J.; Cheng A.-L.
臺大學術典藏 2021-03-19T01:54:21Z Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma Shao Y.-Y.; TSUNG-HAO LIU; Lee Y.-H.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2021-03-19T01:54:20Z Considerations of heterogeneity in clinical trials for hepatocellular carcinoma TSUNG-HAO LIU; Shao Y.-Y.; Lu L.-C.; Shen Y.-C.; Hsu C.; Lin Z.-Z.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2021-03-19T01:54:20Z Successful Hepatic Arterial Infusion of Chemotherapy in a Patient with Advanced Hepatocellular Carcinoma and Impending Liver Failure TSUNG-HAO LIU; Hsu C.-H.; Shao Y.-Y.
臺大學術典藏 2021-03-19T01:54:20Z Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment Lu L.-C.; Lee Y.-H.; Chang C.-J.; Shun C.-T.; Fang C.-Y.; Shao Y.-Y.; TSUNG-HAO LIU; Cheng A.-L.; Hsu C.-H.
臺大學術典藏 2021-03-19T01:54:19Z Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma Shao Y.-Y.; TSUNG-HAO LIU; Hsu C.; Lu L.-C.; Shen Y.-C.; Lin Z.-Z.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏 2021-03-19T01:54:19Z Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; TSUNG-HAO LIU; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2021-03-19T01:54:18Z Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study Lee M.-R.; Yu K.-L.; Kuo H.-Y.; TSUNG-HAO LIU; Ko J.-C.; Tsai J.-S.; Wang J.-Y.
臺大學術典藏 2021-03-19T01:54:18Z Novel systemic therapy for hepatocellular carcinoma Dong Y.; TSUNG-HAO LIU; Yau T.; Hsu C.
臺大學術典藏 2021-03-19T01:54:17Z It takes two to tango: breakthrough advanced hepatocellular carcinoma treatment that combines anti-angiogenesis and immune checkpoint blockade TSUNG-HAO LIU; Shao Y.-Y.; Hsu C.-H.
臺大學術典藏 2021-03-11T08:34:17Z Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study Lee M.-R.;Yu K.-L.;Kuo H.-Y.;Liu T.-H.;Jen-Chang Ko;Tsai J.-S.;Wang J.-Y.; MENG-RUI LEE; KAI-LUN YU; HUNG-YANG KUO; Tsung-Hao Liu; JEN-CHANG KO; Tsai J.-S.; Wang J.-Y.
國立臺中教育大學 2006 金屬迷思概念改變之研究 劉叢浩; Tsung-Hao, Liu

顯示項目 1-18 / 18 (共1頁)
1 
每頁顯示[10|25|50]項目